A/H1N1 flu vaccine set for production

Watch Video

Play Video

The vaccine for the A/H1N1 influenza produced by the Chinese pharmaceutical company Hualan Biological Engineering, has passed an expert evaluation. Another 9 pharmaceutical companies are now taking part in the clinical test phase.

It's expected that by the end of this year, A/H1N1 vaccines produced on the mainland will be able to meet the demands of five percent of the country's population.

The State Food and Drug Administration, says the vaccines produced by domestic pharmaceutical companies will be stored but not administered to the general public. The health administrator will decide on the release of the vaccine depending on the situation of the epidemic.